August 1, 2009American Journal of Clinical Oncology
The Management of Adult Soft Tissue Sarcomas
Key result
The mainstay of treatment for adult soft tissue sarcomas is surgery, with adjuvant radiotherapy improving local control and 5-year overall survival rates ranging from 60% to 80%.
Population
Adults with soft tissue sarcomas
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Reinforces surgery with radiotherapy as standard for adult soft tissue sarcomas; leaves open optimization via prospective trials.
Structured PICO
P
Population
Adults with soft tissue sarcomas
I
Intervention
Surgery (wide excision or radical resection), adjuvant radiotherapy, and/or adjuvant chemotherapy (doxorubicin-containing regimens)
This review outlines the standard management of adult soft tissue sarcomas, emphasizing surgery as the mainstay of treatment with adjuvant therapies for specific cases.
Cite This Study
Mendenhall et al. (2009) conducted a review in Adult Soft Tissue Sarcomas. The mainstay of treatment for adult soft tissue sarcomas is surgery, with adjuvant radiotherapy improving local control and 5-year overall survival rates ranging from 60% to 80%.